0:00Welcome to Base by Base, the papercast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. Glad to be here for another one. Yeah, so let's just jump right in.
0:10You know, there is a really staggering statistical mystery in the world of medicine right now. Oh, absolutely. Men are at a four-time higher risk of developing bladder cancer than women, 4 times. And for a really long time, the medical community hasn't been entirely sure why.
0:27Right, because, I mean, we aren't talking about a sex specific organ here, you know, like the prostate or the ovaries. Exactly. We're talking about the bladder. It's completely shared anatomy. You have one.
0:37I have one. So, why are men losing this biological coin toss 4 times more often than women? It is a profound mystery. And it actually sits right alongside another really major puzzle in oncology. Which is what?
0:52Well, we've known for decades that smoking is a principal risk factor for several tumor types, right? Including bladder cancer. Right. Yeah, smoking is basically the textbook risk factor. Yeah, exactly.
1:04But how exactly does it trigger the disease in the bladder? Like, does the tobacco smoke just act like a, like a scatter gun, just randomly mutating your DNA wherever it happens to land? Or does it do something far more insidious?
1:16Like something really targeted under the surface? Precisely. So imagine your body cells are like a lawn, right? When a disease like cancer forms, Is it just a random weed popping up out of nowhere? Or are factors like your biological sex and your lifestyle, actually, you know, fertilizing specific weeds, years maybe even decades before you ever notice them?
1:37And to answer that, we actually have to look away from the tumor itself. Wait really? Look away from the cancer. Yeah, we have to look at the healthy lawn because by examining normal, non-cancerous tissue, we can actually observe the incredibly early stages of cellular evolution.
1:52We can see the microscopic turf wars happening in your body right now. Wow. Which brings us to the formal recognition for this deep dive. Today, we celebrate the work of Ferial Calvet, Raquel Blanco Martinez Aliscus, Ebold Gonzalez Perez, Naria Lopez, Bigas, Rosa Annarisks, and their collaborative teams at IRB Barcelona, and the University of Washington, who have advanced our understanding of how cancer risk factors shape the normal human bladder.
2:20It's an incredible piece of work. Their research was published in the journal Nature in October 2025. Fresh science. Very fresh. And to truly appreciate the magnitude of what they accomplish, we 1st need to understand the uh, the biological battlefield they were looking at.
2:35Okay, let's unpack this. Wait, so you're telling me my healthy organs aren't just pristine identical copies of my DNA? Not at all. They're actually microscopic battlegrounds of mutant cells fighting for territory.
2:46What's fascinating here is that, yes, the idea of a pristine organ is totally an illusion. It just doesn't exist. It is slightly terrifying. I'm not gonna lie. Well, think about it like this. As you age, the cells in your body divide 1000000s and 1000000s of times, and occasionally during that division process, they make typos in their DNA.
3:04Just accidental copies. Right, just replication errors. These are called somatic mutations. They are spontaneous, acquired changes in your normal, non-reproductive cells. Because of this constant division and this mutation happening over decades, your normal human tissue is actually a mosaic.
3:22It's made up of 1000000s of competing cellular clones, constantly testing out these new mutations in real time. So every single tissue in your body is essentially running its own localized, fiercely competitive evolutionary experiment, just all the time.
3:39That captures the dynamic perfectly. Now, the vast majority of these mutant clones are completely harmless. Right, they just exist. Yeah, they get a typo. It does absolutely nothing, and the cell just goes about its business, but a tiny, tiny fraction of them acquire mutations in specific cancer related genes.
3:54And those give them an edge. Exactly. It gives them a distinct survival advantage over their neighbors. And because they have an advantage, they outcompete the normal cells around them, they literally take over more physical territory in the tissue.
4:07But they aren't cancer yet, right? No, no, not get cancer yet. Not even close, really. But they have taken the very 1st evolutionary steps toward becoming malignant tumors. It completely changes how you view a healthy body.
4:19I mean, it's wild. But if our organs are full of these tiny mutant battles. Why haven't we mapped them clearly? Like if this turf war is happening and everyone listening to this deep dive right now. Why is it such a mystery?
4:35Mostly because they are incredibly small and incredibly hard to find using traditional methods. Like standard DNA tests. Right. Right. Conventional DNA sequencing, what we call bulk sequencing, takes a piece of tissue, and essentially runs it through a blender.
4:49Yeah, it gives you the average DNA of 1000000s of cells all mixed together into one smoothie. If a mutant clone only makes up say, a fraction of a percent of that tissue. Its unique genetic signal is completely drowned out by the overwhelming noise of the normal cells.
5:06Wait, before we talk about how they fixed that noise problem and found these genes, what exactly were they looking at? What is an epithelial brushing? Ah, right. question. Are they just like scraping the inside of the bladder?
5:19Essentially, yes. To get a broad view of this mosaic. The team collected epithelial brushings from relatively large surface areas of the bladder lining. About 2 square centimeters per sample, which, on a cellular level, is massive.
5:33Millions of cells. Millions. And they didn't just look at one random spot either. They sampled the upper part of the bladder, which is called the dome. And the lower funnel like part called the trigone.
5:44Okay, so getting a good geographical map of the organ. Exactly. They did this using tissues from 45 deceased donors, which yielded 79 distinct really high quality samples. And they didn't sequence the entire genome of those samples, right?
5:59I mean, going back to the lawn analogy, they were hunting for specific weeds in the lawn. That's right. Sequencing the whole genome at the depth they needed would be, well, it would be nearly impossible, or at least prohibitively expensive.
6:10So they narrowed it down. Yeah, they targeted 16 specific genes known to be heavily involved in bladder cancer. This included a highly critical regulatory region called the turt promoter, which we'll get to in a minute.
6:24Okay, 16 genes. Right. Now, to your point about finding the signal in the blender noise, they sequenced this targeted DNA at roughly 5000 times depth. 5000 times. Yeah, in aggregate across all those samples, they analyzed about 400,000 haploid genomes.
6:40Okay, let's slow down on that number for a second. 400,000 happily genomes. What does that actually mean in physical terms, like for the listener trying to picture this? Sure. A haploid genome is basically one complete single set of chromosomes. By aggregating 400,000 of them, it basically means they were looking at the genetic equivalent of 400,000 individual cells worth of DNA.
7:01Just for those 16 genes. Exactly. And reading each section 5000 times over ensures that if a mutation only exists in, say, one out of a 1000 cells, they will still catch it. Here's where it gets really interesting.
7:13Finding these hidden clones with regular bulk sequencing is, it's like trying to spot a specific typo by glancing at the cover of a closed book. Right. But the researchers in this study use something called ultra deep DNA duplex sequencing.
7:28Yes. It's like having 5000 proofreaders independently read every single letter on a specific page to guarantee the typo is real and not just, you know, a smudge of ink on the paper. That is a brilliant way to phrase it.
7:41And building on your proofreader analogy. They also gave each letter a microscopic tracking number. Wait, really? A tracking number. Yeah. To ensure the mutations they found were genuine biological changes and not just machine errors introduced during the sequencing process, they used a custom computational pipeline called Deep Yuma Collar.
7:59UMI caller. what does that stand for The UMI stands for a unique molecular identifier. So they are literally attaching a barcode to the DNA. Precisely. Before they even start amplifying and reading the DNA, they attach a unique microscopic barcode to every single original double stranded DNA molecule.
8:18Oh, that's clever. Very. This means that after they make 1000s of copies to sequence them, the computer can trace every single copy back to its original parent molecule. So if a typo shows up in some copies but not others with the exact same barcode, the computer knows it's a machine error and just throws it out.
8:37You got it. If the typo is on both strands of the original molecule, then they know for sure it's a true biological mutation. That is incredible. And this calibration resulted in an incredibly low error rate.
8:50We are talking roughly 4 errors per 1000000 base pairs. Four errors per 100 million. That level of accuracy is just hard to wrap your head around. It is staggering. But it's exactly what you need if you're going to prove that a mutation exists in just a tiny microscopic cluster of cells.
9:06And this staggering accuracy is what allowed them to confidently measure something called positive selection. Okay, define positive selection force. Sure. By comparing the rate of harmless, silent mutations to the rate of function altering mutations.
9:18They could mathematically prove which mutations were actively giving cells a survival advantage. Oh, so they weren't just guessing based on vibes. Definitely not. They could calculate exactly which cellular clones were actively winning the microscopic turf war.
9:32Okay, so now they have this incredibly powerful magnifying glass, right? And 400,000 genomes worth of highly calibrated data. Right. The 1st thing they point that glass at is the elephant in the room from the beginning of our deep dive.
9:47Yeah. The fact that men get this cancer 4 times more often than women. Yes, the big mystery. If the tumor isn't there yet. What did the glass reveal about the normal, seemingly healthy male tissue? It revealed a definitive sex bias already hard at work in the normal tissue.
10:03Men had significantly more truncating driver mutations in specific genes. Which ones? Namely, the genes RBM 10, CDKN1A, and Aired 1A. Okay, I want to make sure I fully understand the mechanics of this.
10:14When you say truncating mutations. How does that actually break the gene? Good question. Think of a protein as a highly specific complex 3D tool. Like a master key. Okay, master. Its physical shape dictates exactly what it can do.
10:28A truncating mutation introduces a premature stop signal in the DNA blueprint. So when the cell builds the protein, it just stops halfway through. Oh, so it just leaves it unfinished? Exactly. The resulting protein is physically cut short.
10:43It loses its 3D shape, meaning it can't bind to what it needs to bind to, and the tool is broken. And what do these 3 specific genes do when they aren't broken? These 3 genes normally act as vital safeguards against uncontrolled cellular growth.
10:58When they are truncated, the brakes are essentially cut. And this is happening more often in men, like their brakes are being cut more often. Here is the crucial biological nuance. This difference happens despite men and women having very similar overall rates of background mutation.
11:12Yes. The total number of random typos happening in the bladder over a lifetime is about the same for both sexes. But the male bladder exhibits a much stronger positive selection for these specific broken genes.
11:25The localized environment of the mail bladder actively rewards cells that break RBM 10, CDKN1A, and Arid 1A. That is wild. So the male bladder isn't generating more mutations overall. It's basically rolling out the red carpet for these specific mutant clones once they inevitably appear.
11:44Right. providing a welcoming environment. It's giving them a selective advantage to grow and conquer territory. that the female bladder environment just doesn't provide. That is the exact mechanism driving the bias.
11:56And the story gets even more complex and frankly more fascinating when we transition from biological sex to lifestyle factors. Right, the smoking bias. Exactly. Let's look at the smoking bias. To understand how tobacco smoke alters this landscape.
12:10We have to talk about the turt promoter. Okay, let's break that down. What exactly is the turd promoter? So turt is a gene that... Plastic caps on the ends of your shoelaces, but for your chromosomes. Oh, I've heard of this, to keep them from frame.
12:28Exactly. Every time a normal cell divides, those caps get a little bit shorter. When they burn down completely, the cell stops dividing and safely dies. It's basically a biological clock. Telomerous is an enzyme that rebuilds those caps, effectively acting as a cellular fountain of youth allowing a cell to divide indefinitely without aging.
12:47So if a cell mutates the promoter, which is essentially the volume dial or the on switch for the turt gene, it turns that fountain of youth on permanently. It makes itself immortal and just refuses to die when it's supposed to.
13:02The data supports that entirely. Activating mutations in the terp promoter are incredibly common in actual bladder tumors. But in the study of normal healthy tissue, the researchers found 56 activating mutations in the TERP promoter.
13:15In completely healthy people. Right. And they weren't distributed evenly among the 45 donors. They discovered these terp mutations were strongly associated with an interaction between 2 specific factors.
13:25Being older than 55 and having a history of smoking. So what does this all mean for smokers? If inhaling carcinogens and tobacco smoke damages DNA, why didn't the smokers just have way more mutations scattered everywhere on the bladder?
13:41That's the logical assumption, right? Yeah. Why was the effect specifically concentrated in the Turk promoter? That is perhaps the most elegant biological insight in the entire study. Tobacco doesn't just act as a random scatter gun of mutations in the bladder.
13:55It doesn't. No, it acts as a promoter. The carcinogens and tobacco create a highly specific localized environment where cells that already happen to have the terp mutation suddenly have a massive competitive advantage.
14:08Oh wow. It allows them to grow and multiply over their normal, non-mutated neighbors incredibly fast. Oh, I see. Going back to our analogy. Smoking isn't necessarily planting the tur weed randomly across the whole lawn.
14:19It's pouring a very specific chemical fertilizer onto the soil that only the turt weed can thrive on. The smoking changes the climate of the lawn to favor the immortal cells. That's the perfect way to visualize it.
14:32The overall mutation density. It wasn't universally higher in smokers, but the specific clones with that treat immortality switch flipped on were expanding aggressively under the influence of tobacco. That makes so much sense.
14:45But we also have to remember that the healthy tissue isn't just a passive victim letting weeds grow and checked. The researchers also found profound evidence of negative selection. I'm, uh, I'm struggling to wrap my head around this negative selection idea.
14:59You mentioned before we started that they found truncating mutations in a gene called FGFR 3 being weeded out. Yes. But if FTFR 3 mutations are sometimes found in actual bladder cancer. Why would the healthy bladder actively fight them?
15:14Wouldn't they be thriving and growing? That's the paradox of cellular evolution. What works in a tumor might be a severe disadvantage and healthy tissue. How so? Well, a malignant tumor is a chaotic, unregulated environment.
15:25But normal tissue is a highly regulated, tightly packed ecosystem with strict rules for survival. In a healthy bladder, breaking the FGFR 3 gene seems to trigger a response that puts the cell at a disadvantage.
15:37Oh, so the normal cells gang up on it. Basically, yeah. The surrounding normal cells essentially outcompete it or force it into apoptosis, which is program, cell death. The healthy ecosystem actively weeds it out.
15:49It really is a highly dynamic ecosystem. And because they looked at so many genomes, 400,000 of them, as we discussed, they were able to observe something called natural saturation mutogenesis. This concept is truly remarkable when you think about the sheer scale.
16:04Explain that for us. Usually, if scientists want to know what every possible mutation in a single gene does, they have to run a saturation mutogenesis experiment in a laboratory. Like with CRISPR. Yeah, they use gene editing tools like CRISPR to painstakingly mutate every single amino acid of a protein in a patriot dish one by one and watch what happens.
16:23That sounds exhausting. It is incredibly slow. And it's totally isolated from the reality of a human body. But here, because they sequence so deeply across 45 human lifetimes, they literally watched nature run that massive CRISPR experiment naturally inside living humans over decades.
16:39Precisely. The sheer volume of data and the depth of the sequencing meant they observed nature testing almost every possible mutation in these 16 target genes. That is amazing. For example, they saw significant positive selection clustered very specifically in the DNA binding domain of the TP 53 gene.
16:58TP 53. That's a famous one Very famous. TP 53 is often called the Guardian of the Genome because it initiates DNA repair. By using humanity as the laboratory rather than a picture dish, they mapped the exact structural weak points of this critical protein based on what actually survives and thrives in a living human bladder.
17:17Okay, so if we connect this to the bigger picture. How does mapping all these microscopic biases? The sex bias, the smoking bias, the natural mutogenesis. How does all of this change the way we view the actual disease of bladder cancer?
17:30It creates a direct, undeniable bridge between the healthy state and the diseased state. The studies clearly notes that mutations in RBM 10 and CDKN1A, the exact genes positively selected in the normal male bladder, are also significantly more abundant in actual fully formed bladder cancers in men.
17:47Meaning the sex bias in cancer doesn't start the day the tumor forms. It starts at the microscopic clone level. Years, or maybe even decades, before tumor is ever declared by a doctor. The groundwork is already laid in the healthy tissue.
18:03The evolutionary trajectory toward cancer is shaped by your biological sex long before the pathology is ever visible on a scan. Now, we must absolutely acknowledge the study's limitations. The researchers are very clear that while they proved that the male bias exists in normal tissue, We don't yet know why the male bladder acts as a red carpet for these mutations.
18:24Right, the mechanism is still unknown. Exactly. Is it internal, driven by sex hormones like testosterone acting on the bladder lining, or is it external, driven by unknown occupational exposures or other lifestyle factors that disproportionately affect men over their lifetimes?
18:39So many variables. too many. That mechanism remains a mystery for future studies to solve. But the clinical implications of just knowing this phenomenon exists are massive. I mean, if we can read the battlefield of a healthy organ today, We aren't just treating cancer anymore.
18:54We're tracking the opposing army's movements decades before they ever declare war on the body. This raises an important question regarding the future of clinical practice. If we have the technology to sequence these clones via ultra deep DNA duplex sequencing.
19:11We could potentially use entirely noninvasive tests to monitor a person's cancer risk over time. Like just a regular screening. Right. Imagine a high risk patient, perhaps an older smoker, providing a simple urine sample or a bladder lavage during a routine checkup.
19:27Oh, and you just sequence the cells they shed naturally. Yes, a lab could read the clonal landscape of their bladder lining. You could literally see if the Turk clones or the RBM 10 clones are actively expanding their territory and intervene with preventative measures before a tumor ever takes shape.
19:43And it completely changes drug design too, that natural saturation mutogenesis we talked about earlier. It means we can design targeted drugs based on exactly which structural mutations give cells a survival advantage in real living human tissue, rather than relying on artificial lab conditions.
19:59It pushes personalized cancer medicine into an entirely new frontier. We are moving away from a reactive model of waiting to treat visible tumors toward a proactive model of actively managing the microscopic cellular ecology of our organs.
20:14It's a profound shift in perspective. So to bring this all together for you, the landscape of your normal healthy tissue is not a static pristine blueprint. It is deeply shaped by your biological sex and your lifestyle choices, like smoking.
20:28By using ultra deep sequencing, scientists can now map the microscopic battlegrounds of cellular clones, revealing the very earliest roots of cancer risk long before a tumor ever develops. What does this mean for how we define a healthy organ if every tissue in our body is actually a mosaic of microscopic winners and losers constantly fighting for survival?
20:48incredible to think about. And, you know, if our normal tissues are full of these competing mutant clones, it makes you wonder, could the future of preventative medicine be less about developing toxic drugs at nuke cancer, and more about finding clever ways to simply help our good, normal clones naturally outcompete the dangerous ones for territory?
21:08That is a fascinating thought to end on. This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description.
21:20If you enjoyed this, follow or subscribe in your podcast app and leave a five-star rating. If you'd like to support our work, use the donation link in the description. Now stay with us for an original track, created especially for this episode, and inspired by the article you've just heard about.
21:33Thanks for listening, and join us next time as we explore more science base by base.
